Literature DB >> 19748056

Transverse myelitis as a rare, serious complication of Mycoplasma pneumoniae infection.

Györgyi Csábi1, Hedvig Komáromy, Katalin Hollódy.   

Abstract

We report on the first published case of a Mycoplasma pneumoniae-associated transverse myelitis appearing in childhood and leading to persistent paraplegia and bowel and bladder dysfunctions. Magnetic resonance imaging of the spinal cord indicated extensive transverse myelitis extending from T(5)-T(12). A repeated scan established spinal cord atrophy in the affected area. Various therapies (methylprednisolone pulse therapy, plasmapheresis, and roxythromycine) produced no clinical effect.

Entities:  

Mesh:

Year:  2009        PMID: 19748056     DOI: 10.1016/j.pediatrneurol.2009.04.029

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

Review 1.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

2.  Mycoplasma pneumoniaeassociated transverse myelitis presenting as asymmetric flaccid paralysis.

Authors:  Shafee Salloum; Ajay Goenka; Elizabeth Ey
Journal:  Clin Pract       Date:  2019-09-12

3.  Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent.

Authors:  Yasemin Topcu; Erhan Bayram; Pakize Karaoglu; Uluc Yis; Handan Guleryuz; Semra Hiz Kurul
Journal:  J Pediatr Neurosci       Date:  2013-01

Review 4.  Infectious myelitis.

Authors:  Cornelia Mihai; Burk Jubelt
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 6.030

Review 5.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.